Doxycycline is a broad-spectrum antibiotic synthetically derived from oxytetracycline. It is a second-generation tetracycline that was first discovered in 1967. Second-generation tetracyclines exhibit lesser toxicity than first-generation tetracyclines. Doxycycline is used to treat a wide variety of gram-positive and gram-negative bacterial infections. It is also used to treat acne and malaria.
Doxycycline is indicated for the treatment of various infections by gram-positive and gram-negative bacteria, aerobes and anaerobes, as well other types of bacteria, including:
It is also used to treat infections caused by the following gram-negative microorganisms:
ATS Clinical Research, Santa Monica, California, United States
Melissa L. F. Knuckles M.D., P.S.C., Richmond, Kentucky, United States
Dadeland Dermatology, Coral Gables, Florida, United States
The Ottawa Hospital, Ottawa, Ontario, Canada
Ottawa Hospital, Ottawa, Ontario, Canada
Academic Unit of Respiratory Medicine, Royal Free Hospital, London, United Kingdom
University of California San Diego Clinical trials Research Institute, La Jolla, California, United States
Antibiotic Centre for Primary Care, University of Oslo, Oslo, Norway
University of Southern California, Los Angeles, California, United States
Radboud university medical center, Nijmegen, Gelderland, Netherlands
ICO Paul Papin, Angers, France
CHU Jean Minjoz, Besançon, France
Centre Hospitalier Départemental Les Oudairies, La Roche Sur Yon, France
Michigan Center for Research Corp, Clinton Township, Michigan, United States
Burke Pharmaceutical Research, Hot Springs, Arkansas, United States
Oregon Medical Research Center, PC, Portland, Oregon, United States
Berlin Center, Boynton Beach, Florida, United States
Palos Verdes Dermatology Associates, Rolling Hills Estates, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.